Investigation of the effects of heart failure with preserved ejection fraction (HFpEF) on cerebral small vessel disease
- Conditions
- Heart failure with preserved ejection fraction (HFpEF)
- Registration Number
- DRKS00031583
- Lead Sponsor
- niversitätsklinikum Magdeburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 102
Inclusion Criteria
HFpEF
MRI suitable
Arterial hypertension
Exclusion Criteria
MRI contraindication
Dementia
Depression
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CSVD in accordance to STIVE criteria
- Secondary Outcome Measures
Name Time Method Cognition, physical fitness, inflammatory biomarker, lifestyle factors
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link HFpEF to cerebral small vessel disease progression in DRKS00031183?
Are there specific biomarkers that correlate with cerebral small vessel disease severity in HFpEF patients?
How does HFpEF observational study DRKS00031583 compare to interventional trials targeting cerebral small vessel disease?
What are the potential adverse events associated with observational HFpEF studies on cerebral small vessel disease?
What drug targets are being explored for treating cerebral small vessel disease in HFpEF patients based on DRKS00031583 findings?